期刊文献+

Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women 被引量:3

Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women
原文传递
导出
摘要 Background Hypertension (HTN) is a major determinant of various cardiovascular events. Plasma levels of plasminogen activator inhibitor 1 (PAl-l) modulate this risk. A deletion/insertion polymorphism within the PAl-1 loci (4G/4G, 4G/5G, 5G/5G) affects the expression of this gene. The present study investigated the association between PAl-1 loci polymorphisms and HTN in Korean women. Methods Korean women (n=1312) were enrolled in this study to evaluate the association between PAl-1 4G/5G gene polymorphisms and HTN as well as other metabolic risk factors. PAl-1 loci polymorphisms were investigated using polymerase chain reaction amplification and single-strand conformation polymorphism analysis. Results The three genotype groups differed with respect to systolic blood pressure (P=0.043), and diastolic blood pressure (P=0.009) but not with respect to age, body mass index, total cholesterol, low or high density lipoprotein cholesterol, triglycerides, or fasting blood glucose. Carriers of the PAl-1 4G allele had more hypertension significantly (PAl-1 4G/5G vs. PAl-1 5G/5G, P=0.032; PAl-1 4G/4G vs. PAl-1 5G/5G, P=0.034). When stratified according to PAl-1 4G/5G polymorphism, there was no significant difference in all metabolic parameters among PAl-1 genotype groups in patients with HTN as well as subjects with normal blood pressure. The estimated odds ratio of the 4G/4G genotype and 4G/5G for HTN was 1.7 (P=0.005), and 1.6 (P=0.015), respectively. Conclusion These findings might indicate that PAl-1 loci polymorphisms independently contribute to HTN and that gene-environmental interaction may be not associated in Korean women. Background Hypertension (HTN) is a major determinant of various cardiovascular events. Plasma levels of plasminogen activator inhibitor 1 (PAl-l) modulate this risk. A deletion/insertion polymorphism within the PAl-1 loci (4G/4G, 4G/5G, 5G/5G) affects the expression of this gene. The present study investigated the association between PAl-1 loci polymorphisms and HTN in Korean women. Methods Korean women (n=1312) were enrolled in this study to evaluate the association between PAl-1 4G/5G gene polymorphisms and HTN as well as other metabolic risk factors. PAl-1 loci polymorphisms were investigated using polymerase chain reaction amplification and single-strand conformation polymorphism analysis. Results The three genotype groups differed with respect to systolic blood pressure (P=0.043), and diastolic blood pressure (P=0.009) but not with respect to age, body mass index, total cholesterol, low or high density lipoprotein cholesterol, triglycerides, or fasting blood glucose. Carriers of the PAl-1 4G allele had more hypertension significantly (PAl-1 4G/5G vs. PAl-1 5G/5G, P=0.032; PAl-1 4G/4G vs. PAl-1 5G/5G, P=0.034). When stratified according to PAl-1 4G/5G polymorphism, there was no significant difference in all metabolic parameters among PAl-1 genotype groups in patients with HTN as well as subjects with normal blood pressure. The estimated odds ratio of the 4G/4G genotype and 4G/5G for HTN was 1.7 (P=0.005), and 1.6 (P=0.015), respectively. Conclusion These findings might indicate that PAl-1 loci polymorphisms independently contribute to HTN and that gene-environmental interaction may be not associated in Korean women.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第7期1249-1253,共5页 中华医学杂志(英文版)
关键词 HYPERTENSION plasminogen activator inhibitor 1 POLYMORPHISM hypertension plasminogen activator inhibitor 1 polymorphism
  • 相关文献

参考文献1

二级参考文献11

  • 1Gao M,Nakabayashi M, Sakura M, et al. The imbalance of plasminogen activators and inhibitor in preeclampsia.J Obstet Gynaecol Res,1996,22∶9-16.
  • 2Estelles A,Gilabert J,Aznar J,et al.Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.Blood,1989,74∶1332-1338.
  • 3Eriksson P, Kallin B, van't Hooft FM, et al. Allele-specific increase in basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardia infarction. Proc Natl Acad Sci U S A, 1995,92∶1851-1855.
  • 4Visanji JM,Seargent J,Tahri D,et al.Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden.Br J Haematol,2000,110∶135-138.
  • 5Juhan-Vague I,Alessi MC.Plasminogen activator inhibitor-1 and atherothrombosis.Thromb Haemost,1993,70∶138-143.
  • 6Guan LX,Zhang AJ,Song BH,et al. The relationship between angiotensinogen gene CD235 Met→Thr substitution polymorphism and brain infarction in Chinese. Chin J Med Genet,2000,17∶336-339.[管立学,张爱娟,宋保华,等.血管紧张
  • 7Guan LX,Ji XW,Wang JX,et al. Association of plasminogen activitor inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients. Chin J Med Genet,2002,19∶393-396.[管立学,季祥武,王敬先,等. 纤溶酶原激
  • 8Gilabert J,Estelles A,Aznar J,et al.Contribution of platlets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.Thromb Haemost,1990,63∶361-366.
  • 9Estelles A,Gilabert J,Andres C,et al.Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.Thromb Haemost,1990,64∶281-285.
  • 10Glueck CJ,Phillips H,Cameron D,et al.The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene and independent risk factor for serious pregnancy complications.Metabolism, 2000,49∶845-852.

共引文献1

同被引文献4

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部